These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 7538513)
1. Levels of hepatitis C virus (HCV) RNA in serum and their relationship to levels of immunoglobulin M and G antibodies against HCV core protein. Chen M; Sönnerborg A; Sällberg M J Clin Microbiol; 1995 Mar; 33(3):778-80. PubMed ID: 7538513 [TBL] [Abstract][Full Text] [Related]
2. Quantitative assessment of hepatitis C virus RNA and IgM antibodies to hepatitis C core in chronic hepatitis C. Martinelli AL; Brown D; Braun HB; Michel G; Dusheiko GM J Hepatol; 1996 Jan; 24(1):21-6. PubMed ID: 8834020 [TBL] [Abstract][Full Text] [Related]
3. IgM and IgG antibodies to hepatitis C virus in patients with mixed cryoglobulinaemia. L'Abbate A; Cutrupi S; Rognetta M; Fabiano C; Craxi A Clin Exp Immunol; 1993 Nov; 94(2):313-6. PubMed ID: 7693384 [TBL] [Abstract][Full Text] [Related]
4. Is the detection of anti-hepatitis C virus core IgM influenced by the presence of serum rheumatoid factor? Pawlotsky JM; Remire J; Darthuy F; Intrator L; Udin L; Dhumeaux D; Duval J J Med Virol; 1995 Jan; 45(1):68-70. PubMed ID: 7536232 [TBL] [Abstract][Full Text] [Related]
5. HCV core IgM and IgG antibodies in blood donors. Kapprell HP; Majnak A; Medgyesi GA; Szabó JE; Michel G; Albrecht M; Heyermann H; Hampl H; Troonen H Vox Sang; 1995; 68(1):57-8. PubMed ID: 7536991 [No Abstract] [Full Text] [Related]
6. Immunoglobulin G and M hepatitis C virus core antibody (JCC.2) response in chimpanzees infected experimentally with hepatitis C virus. Shioda A; Moriyama M; Hayashi N; Sugitani M; Uchida T; Shikata T; Nishizono A; Abe K; Arakawa Y Intervirology; 2000; 43(3):146-53. PubMed ID: 11044808 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus RNA in patients with anti-HCV on hemodialysis. Relationship to transaminase levels. Garcia-Valdecasas J; Bernal C; Cerezo S; Garcia F; Montiel N; Leyva A; Umana WO; Bosch JP ASAIO J; 1994; 40(3):M450-3. PubMed ID: 8555556 [TBL] [Abstract][Full Text] [Related]
8. The fluctuations of hepatitis C virus RNA and IgM anti-HCV (core) serum levels correlate with those of alanine aminotransferases during the hepatitis relapses of patients treated with interferon. Negro F; Abate ML; Mondardini A; Baldi M; Leandro G; Lombardi S; Wolfe L; Ryff JC; Verme G; Brunetto MR J Viral Hepat; 1995; 2(4):171-4. PubMed ID: 7489343 [TBL] [Abstract][Full Text] [Related]
9. IgM antibody to a hepatitis C virus core peptide (CP14) for monitoring activity of liver disease in patients with acute or chronic hepatitis C. Nagayama R; Miyake K; Tsuda F; Okamoto H J Med Virol; 1994 Mar; 42(3):311-7. PubMed ID: 7516423 [TBL] [Abstract][Full Text] [Related]
10. Significance of IgM anti-HCV core level in chronic hepatitis C. Papatheodoridis GV; Delladetsima JK; Katsoulidou A; Sypsa V; Albrecht M; Michel G; Hatzakis A; Tassopoulos NC J Hepatol; 1997 Jul; 27(1):36-41. PubMed ID: 9252071 [TBL] [Abstract][Full Text] [Related]
11. Significance of anti-hepatitis C virus core IgM antibodies in patients with chronic hepatitis C. Pawlotsky JM; Darthuy F; Rémiré J; Pellet C; Udin L; Stuyver L; Roudot-Thoraval F; Duvoux C; Douvin C; Mallat A J Med Virol; 1995 Nov; 47(3):285-91. PubMed ID: 8551282 [TBL] [Abstract][Full Text] [Related]
12. Immunoglobulin M and A antibodies to hepatitis C core antigen in chronic hepatitis C virus infection. Lau GK; Lesniewski R; Johnson RG; Davis GL; Lau JY J Med Virol; 1994 Sep; 44(1):1-4. PubMed ID: 7528259 [TBL] [Abstract][Full Text] [Related]
13. Distinguishing acute from symptomatic chronic hepatitis C virus (HCV) infection by site-directed serology of the HCV structural proteins. Zhang ZX; Chen M; Sönnerborg A; Weiland O; Sällberg M J Infect Dis; 1995 May; 171(5):1356-9. PubMed ID: 7538552 [TBL] [Abstract][Full Text] [Related]
14. IgM antibody response in acute hepatitis C viral infection. Clemens JM; Taskar S; Chau K; Vallari D; Shih JW; Alter HJ; Schleicher JB; Mimms LT Blood; 1992 Jan; 79(1):169-72. PubMed ID: 1309424 [TBL] [Abstract][Full Text] [Related]
15. IgG and IgM core antibodies and viral replication in hepatitis C virus carriers. Yuki N; Hayashi N; Hagiwara H; Naito M; Ohkawa K; Katayama K; Kasahara A; Fusamoto H; Kamada T J Hepatol; 1994 Jul; 21(1):110-4. PubMed ID: 7525692 [TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up study of serum IgM antibody to hepatitis C virus (HCV), HCV replication, and liver disease outcome in chronic hepatitis C. Quiroga JA; Herrero M; Castillo I; Navas S; Pardo M; Carreño V J Infect Dis; 1994 Sep; 170(3):669-73. PubMed ID: 7521377 [TBL] [Abstract][Full Text] [Related]
17. IgM antibody response to the hepatitis C virus core protein in intravenous drug users. Toniutto P; Falleti E; Gasparini V; Fabris C; Tisminetzky SG; Lombardelli T; Pacco P; Satta A; Pirisi M Diagn Microbiol Infect Dis; 1999 Feb; 33(2):69-73. PubMed ID: 10091028 [TBL] [Abstract][Full Text] [Related]
18. IgM anti-hepatitis C virus core antibodies as marker of recurrent hepatitis C after liver transplantation. Negro F; Giostra E; Rubbia-Brandt L; Mentha G; Colucci G; Morel P; Quadri R; Perrin L; Hadengue A J Med Virol; 1998 Nov; 56(3):224-9. PubMed ID: 9783689 [TBL] [Abstract][Full Text] [Related]
19. Clinical usefulness of an assay for hepatitis C virus core in the diagnosis of non-A, non-B hepatitis and monitoring of the response to interferon therapy. Kawano S; Tanaka M; Fujiyama S; Sato S; Taura Y; Goto M; Chikazawa H; Sato T J Gastroenterol Hepatol; 1994; 9(3):217-22. PubMed ID: 7519894 [TBL] [Abstract][Full Text] [Related]
20. Anti-GOR without anti-HCV core is not associated with hepatitis C viremia. Bååth L; Widell A Vox Sang; 1994; 66(2):151. PubMed ID: 7514327 [No Abstract] [Full Text] [Related] [Next] [New Search]